Circ_0000524/miR-500a-5p/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy

Zhiqiang Sun1, Qingqing Xu1, Yali Ma1

  • 1Department of Nephrology, Huaihe Hospital of Henan University, Kaifeng, China.

Abstract

Insights

Circ_0000524 promotes podocyte apoptosis in membranous nephropathy (MN) by regulating the miR-500a-5p/CXCL16 pathway. Inhibiting circ_0000524 may offer a therapeutic strategy for MN.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Podocyte apoptosis is a key feature of membranous nephropathy (MN).
  • Circ_0000524 is linked to MN, but its role in podocyte apoptosis and underlying mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of circ_0000524 in podocyte apoptosis in MN.
  • To elucidate the molecular mechanisms involving circ_0000524, miR-500a-5p, and CXCL16 in MN.

Main Methods:

  • Quantitative real-time PCR and Western blot to assess gene and protein expression.
  • Angiotensin II (AngII) to induce podocyte injury.
  • Flow cytometry for apoptosis analysis.
  • Dual-luciferase reporter, RNA immunoprecipitation, and pull-down assays to determine molecular interactions.

Main Results:

  • Circ_0000524 and CXCL16 were upregulated, while miR-500a-5p was downregulated in MN tissues and AngII-treated podocytes.
  • Circ_0000524 depletion reduced podocyte apoptosis, an effect reversed by miR-500a-5p inhibition.
  • MiR-500a-5p directly targeted CXCL16, and circ_0000524 knockdown increased miR-500a-5p, thereby decreasing CXCL16.
  • MiR-500a-5p upregulation suppressed apoptosis, which was reversed by CXCL16 overexpression.

Conclusions:

  • The circ_0000524/miR-500a-5p/CXCL16 pathway plays a crucial role in regulating podocyte apoptosis in MN.
  • Targeting this pathway may represent a novel therapeutic approach for MN.